Profil
Mr. Michal Fisher is an Independent Director at CNS Pharmaceuticals, Inc. and a Chief Business Officer at BioGenCell Ltd. He is on the Board of Directors at CNS Pharmaceuticals, Inc. Mr. Fisher was previously employed as a Head-Corporate Development by LifeSci Partners.
He received his undergraduate degree from Bar-Ilan University and a graduate degree from Bar-Ilan University.
Aktiva positioner av Michal Fisher
| Företag | Position | Start |
|---|---|---|
| CNS PHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2026-05-04 |
BioGenCell Ltd.
BioGenCell Ltd. BiotechnologyHealth Technology Develops cellular therapies that treat blood flow problems | Företagsledare/Principal | - |
Tidigare kända positioner av Michal Fisher
| Företag | Position | Slut |
|---|---|---|
LifeSci Partners
LifeSci Partners Miscellaneous Commercial ServicesCommercial Services Operates as an integrated life sciences consulting platform that offers investor relations, investment banking, communications and strategy consulting | Företagsledare/Principal | 2025-01-02 |
Michal Fishers utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Bar-Ilan University
Bar-Ilan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioGenCell Ltd.
BioGenCell Ltd. BiotechnologyHealth Technology Develops cellular therapies that treat blood flow problems | Health Technology |
CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical drugs | Health Technology |
LifeSci Partners
LifeSci Partners Miscellaneous Commercial ServicesCommercial Services Operates as an integrated life sciences consulting platform that offers investor relations, investment banking, communications and strategy consulting | Commercial Services |
















